Page results
-
UCLH is committed to not only treat patients’ illnesses but to provide an environment and an experience which contributes to patients’ general wellbeing.
-
Mark Emberton joined the board as a non-executive director on 1 September 2022. He is Professor of Intervention Oncology within the Division of Surgery and Dean of the Faculty of Medical Science at University College London.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
Ibrahim Abubakar is Vice Provost (Health) and Professor of Infectious Disease Epidemiology at UCL. He is a member of the Global Preparedness Monitoring Board, University College London NHS Trust Board, UCL Partners Board and the Board of Resolve to Save Lives.
-
UCLH doctor 1 of 10 international members elected to National Academy of Medicine
-
UCLH Director of Research and Director of the UCLH BRC Professor Bryan Williams has received an award for outstanding contributions to research in the field of hypertension (high blood pressure).
-
3000 participants have been recruited to a clinical trial led by UCL and UCLH aimed at reducing the number of patients with breast cancer who are given chemotherapy unnecessarily.
-
Term 01/09/25 to 31/08/28
-
Pop-up clinics in Islington will make it easier for people who are eligible for the Covid-19 vaccine – especially those who are elderly, homeless, vulnerable or in need of support – to get it closer to home.
-
The UCLH trauma and orthopaedics team has reached a milestone of 1000 operations on hips and knees using the Mako robot.
File results
-
FOI/2024/0628 - Service personnel/ armed force families access to speech and language therapy for children who stammer
-
FOI/2024/0633 - Adults, children diagnosed/ living with Glycogen storage disease type V (Mcardle's disease)
-
FOI/2024/0635 - Patient incidences/ injuries due to chiropractic treatment
-
FOI/2024/0648 - Performance management Policy for July 2020 to November 2022
-
FOI/2024/0651 - Family history units/ familial cancer services
-
FOI/2024/0652 - Overseas visitors invoiced in 2023/24
-
FOI/2024/0662 - Treatment of haematology/ Myeloprolifeative diseases/ Non Hodgkin Lymphoma/ Chronic Lymphocytic Leukaemia/ Mantle Cell Lymphoma
-
FOI/2024/0663 - Diagnosis discharge codes and cases 2018-19 to 2022-23
-
FOI/2024/0667 - Agency/ bank staff, master/neutral vendor/ contract and contact details 2023/24
-
FOI/2024/0668 - Doctors shifts covered by Physician Associates 01/04/2024-01/09/2024